1. Others
  2. Drug Derivative
  3. Imexon

Imexon (BM 06002) is an iminopyrrolidone aziridine with anti-cancer activity.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Imexon

Imexon 화학구조

CAS No. : 59643-91-3

사이즈 가격 재고 수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
해외재고보유
Solution
10 mM * 1 mL in DMSO 해외재고보유
Solid
5 mg 해외재고보유
10 mg 해외재고보유
25 mg 해외재고보유
50 mg 해외재고보유
100 mg   견적 받기  
200 mg   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Imexon

  • Biological Activity

  • Protocol

  • 순도&문서

  • References

  • 고객리뷰

제품 설명

Imexon (BM 06002) is an iminopyrrolidone aziridine with anti-cancer activity.

Cellular Effect
Cell Line Type Value Description References
A-375 IC50
324 3
Compound: imexon
Inhibition of cell growth in (A375) melan cell line
Inhibition of cell growth in (A375) melan cell line
[PMID: 9986721]
A-375 IC50
324 3
Compound: imexon
Inhibition of cell growth in (A375) melan cell line
Inhibition of cell growth in (A375) melan cell line
[PMID: 9986721]
L1210 IC50
477 3
Compound: imexon
Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay
Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay
[PMID: 9986721]
A549 IC50
> 72 3
Compound: imexon
Inhibition of cell growth in (A-549) lung cell line
Inhibition of cell growth in (A-549) lung cell line
[PMID: 9986721]
L1210 IC50
612 3
Compound: imexon
Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay
Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay
[PMID: 9986721]
A549 IC50
>72 3
Compound: imexon
Inhibition of cell growth in (A-549) lung cell line
Inhibition of cell growth in (A-549) lung cell line
[PMID: 9986721]
L1210 IC50
477 3
Compound: imexon
Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay
Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay
[PMID: 9986721]
L1210 IC50
612 3
Compound: imexon
Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay
Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay
[PMID: 9986721]
L1210 IC50
477 3
Compound: imexon
Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay
Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay
[PMID: 9986721]
L1210 IC50
612 3
Compound: imexon
Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay
Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay
[PMID: 9986721]
MCF7 IC50
>18 3
Compound: imexon
Inhibition of cell growth in (MCF7 breast) dox cell line
Inhibition of cell growth in (MCF7 breast) dox cell line
[PMID: 9986721]
MCF7 IC50
> 18 3
Compound: imexon
Inhibition of cell growth in (MCF7 breast) dox cell line
Inhibition of cell growth in (MCF7 breast) dox cell line
[PMID: 9986721]
OVCAR-3 IC50
640 3
Compound: imexon
Inhibition of cell growth in (OVCAR-3) ovarian cell line
Inhibition of cell growth in (OVCAR-3) ovarian cell line
[PMID: 9986721]
MCF7 IC50
> 18 3
Compound: imexon
Inhibition of cell growth in (MCF7 breast) mitox cell line
Inhibition of cell growth in (MCF7 breast) mitox cell line
[PMID: 9986721]
RPMI-8226 IC50
115 3
Compound: imexon
Inhibition of cell growth in drug resistant 8226 myeloma cell line
Inhibition of cell growth in drug resistant 8226 myeloma cell line
[PMID: 9986721]
MCF7 IC50
> 18 3
Compound: imexon
Inhibition of cell growth in drug sensitive MCF-7 breast cell line
Inhibition of cell growth in drug sensitive MCF-7 breast cell line
[PMID: 9986721]
RPMI-8226 IC50
17 3
Compound: imexon
Inhibition of cell growth in drug sensitive 8226 myeloma cell line
Inhibition of cell growth in drug sensitive 8226 myeloma cell line
[PMID: 9986721]
OVCAR-3 IC50
640 3
Compound: imexon
Inhibition of cell growth in (OVCAR-3) ovarian cell line
Inhibition of cell growth in (OVCAR-3) ovarian cell line
[PMID: 9986721]
WiDr IC50
>72 3
Compound: imexon
Inhibition of cell growth in drug resistant WiDr colon cell line
Inhibition of cell growth in drug resistant WiDr colon cell line
[PMID: 9986721]
RPMI-8226 IC50
115 3
Compound: imexon
Inhibition of cell growth in drug resistant 8226 myeloma cell line
Inhibition of cell growth in drug resistant 8226 myeloma cell line
[PMID: 9986721]
RPMI-8226 IC50
17 3
Compound: imexon
Inhibition of cell growth in drug sensitive 8226 myeloma cell line
Inhibition of cell growth in drug sensitive 8226 myeloma cell line
[PMID: 9986721]
WiDr IC50
> 72 3
Compound: imexon
Inhibition of cell growth in drug resistant WiDr colon cell line
Inhibition of cell growth in drug resistant WiDr colon cell line
[PMID: 9986721]
WiDr IC50
> 72 3
Compound: imexon
Inhibition of cell growth in drug sensitive WiDr colon cell line
Inhibition of cell growth in drug sensitive WiDr colon cell line
[PMID: 9986721]
In Vitro

Imexon (BM 06002) induces oxidative stress in the ER, activates an ER stress response. Imexon (BM 06002) does not significantly alter the levels of eIF2B5, however there is a dose-dependent increase in the phosphorylation of eIF2alpha, as well as an increase in the levels of GTP exchange protein eIF2B2 in MiaPaCa-2, Panc-1, and BxPC3 cells[1]. Imexon (BM 06002) induces single-stranded breaks in the human A375 melanoma cells but only significantly at the highest concentrations for each agent compared to controls. Imexon plus DTIC cytotoxicity is additive[2]. Imexon (BM 06002) show inhibitory activities against MiaPaCa-2, Panc-1 and BxPC3, with IC50s of 275.5 ± 54.2, 147.4 ± 4.7 and 355.7 ± 114.7 μM[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Imexon (BM 06002) in combination with DTIC results in an increase in the peak plasma imexon level in non-tumor-bearing mice. The combination of both drugs increases plasma imexon AUC by 22% (p=0.026). Imexon (BM 06002) (100 mg/kg/day, i.v.) treatment decreases the body weight of SCID mice bearing human A375 melanoma tumors, but there is no significant difference in tumor growth[2]. Imexon (BM 06002) (100 mg/kg) in combination with GEM shows synergistic inhibition of Panc-1 tumor growth in SCID mice.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial
분자량

111.10

화학식

C4H5N3O

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O=C1N2CC2C(N)=N1

선적

Room temperature in continental US; may vary elsewhere.

보관

4°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

용액&용해도
In Vitro: 

DMSO : 62.5 mg/mL (562.56 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H2O : 12.5 mg/mL (112.51 mM; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 9.0009 mL 45.0045 mL 90.0090 mL
5 mM 1.8002 mL 9.0009 mL 18.0018 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • 몰농도 계산기

  • 농도 희석 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
순도&문서

Purity: 98.12%

References
Cell Assay 
[1]

Cell survival for the siRNA screening experiments are calculated by the conversion of resazurin to resorufin by metabolically active cells resulting in a fluorescent product. Confirmatory growth inhibition assays with eIF2b silencing are done using the methyl-thiazolyl-diphenyl-tetrazolium bromide (MTT) assay. Cell growth inhibition data are expressed as percent survival, compared to untreated cells. The IC50 is defined as the drug concentration required to produce 50% growth inhibition.

MCE 는 독립적으로 이러한 방법들의 정확성을 확인하지 않았습니다. 참고용으로만 봐주십시오.

Animal Administration
[2]

The effect of the combination on tumor growth in vivo is evaluated in 25-30 g male SCID mice (n=8/group). Mice receive 5×106 A375 cells subcutaneously and are pair matched on day 30, when the average tumor burden is approximately 100 mm3. Treatment begins the following day, as follows: (i) saline vehicle control; (ii) 80 mg/kg/day DTIC; (iii) 100 mg/kg/day imexon; (iv) a combination of both drugs at the same doses. Drugs are administered (i.p.) for nine consecutive days and imexon is administered 15 min before DTIC when combined. Measurement of tumor burden and body weights are made every 3-4 days. Tumor burden (mm3) is calculated as (length × width2)/2.

MCE 는 독립적으로 이러한 방법들의 정확성을 확인하지 않았습니다. 참고용으로만 봐주십시오.

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O / DMSO 1 mM 9.0009 mL 45.0045 mL 90.0090 mL 225.0225 mL
5 mM 1.8002 mL 9.0009 mL 18.0018 mL 45.0045 mL
10 mM 0.9001 mL 4.5005 mL 9.0009 mL 22.5023 mL
15 mM 0.6001 mL 3.0003 mL 6.0006 mL 15.0015 mL
20 mM 0.4500 mL 2.2502 mL 4.5005 mL 11.2511 mL
25 mM 0.3600 mL 1.8002 mL 3.6004 mL 9.0009 mL
30 mM 0.3000 mL 1.5002 mL 3.0003 mL 7.5008 mL
40 mM 0.2250 mL 1.1251 mL 2.2502 mL 5.6256 mL
50 mM 0.1800 mL 0.9001 mL 1.8002 mL 4.5005 mL
60 mM 0.1500 mL 0.7501 mL 1.5002 mL 3.7504 mL
80 mM 0.1125 mL 0.5626 mL 1.1251 mL 2.8128 mL
100 mM 0.0900 mL 0.4500 mL 0.9001 mL 2.2502 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

최근 본 상품:

온라인 문의

Your information is safe with us. * Required Fields.

상품명

 

Requested Quantity *

고객명 *

 

호칭

메일주소 *

 

전화번호 *

Department

 

회사명 *

City

Country or Region *

     

비고

대량구매 문의

Inquiry Information

상품명:
Imexon
Cat. No.:
HY-15385
수량:
MCE Japan Authorized Agent: